Links

Homepage

Stock List

Search by Ticker

News

Login

Bausch Health Companies Inc (TSX:BHC)
Stock Analysis

BHC.TO25.81
▲ 1.89%0.48

Stock Analysis

The following stock analysis is based on 7.8 years of data (i.e. since Nov 02, 2012). All the stock history has been downloaded.

Stock Exchange

Bausch Health Companies Inc trades on the Toronto exchange in CAD dollars.

Sector

It is in the healthcare sector.

Current Status of Bausch Health Companies Inc

It is currently trading at $25.81 ($25.33 the previous day).

Financials

The current Canada / US exchange rate is 1.3259.



Will This Trend Continue?

The year over year average increase is -40.5% per year assuming steady exponential growth. The actual 5 year average is -17.74. Details on the individual increase in one year intervals is provided below.

Past PerformanceAverage PricePercent Change
1 year29.761008403361-4.9+ Above Average
2 year31.30083916083933.6+ Above Average
3 year23.43329113924110.3+ Above Average
4 year21.237407407407-81.5- Below Average
5 year114.55086792453-46.2- Below Average

Risk

The worst drop it has had in recent years is -96.7%. It has a up and down shape to the stock curve, which means the stock can have significant gains followed by losses. Good for day trading, but needs to be watched if held for any significant amount of time.

Stock shape test

DAYS AG0PRICE
1022.88RISING
3024.41DROPPING
6026.3DROPPING
15030.15DROPPING
36531.56DROPPING
80028.54RISING
120011.45RISING
160034.93DROPPING
2000207.95DROPPING
!!!!!!!!!!!! WARNING STOCK DROPPING !!!!!!!!!!!!!!!!!

Tradingview BuySell Widget

Yahoo News Feed

Why Bausch Health (BHC) Might Surprise This Earnings Season

Wed, 05 Aug 2020 14:45:02 Bausch Health (BHC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.... Read Full Article

Bausch Health Resolves Canadian Securities Class Action

Wed, 05 Aug 2020 11:00:00 Bausch Health Companies Inc. (NYSE/TSX: BHC) (and"Bausch Healthand" or the and"Companyand"), today announced that the parties in the Canadian securities class action (Cattuci et al. v. Valeant Pharmaceuticals International Inc. et. al., Court File No.: 500-06-000783...... Read Full Article

Bausch Health to pay $45 million fine to settle Philidor charges

Fri, 31 Jul 2020 21:30:00 Bausch Health Cos. will pay a $45 million fine to settle charges that the company misled investors in financial statements when it was known as Valeant Pharmaceuticals, according to the Securities and Exchange Commission late Friday. The SEC also fined then-Valeant ...... Read Full Article

Bausch Health, three former executives agree to penalties to resolve U.S. SEC charges

Fri, 31 Jul 2020 20:51:07 Bausch Health Companies Inc lt;BHC.TOgt; has agreed to pay $45 million, and three of former top executives also agreed to penalties, to settle charges of improper revenue recognition and misleading disclosures in U.S. regulatory filings, the U.S. ...... Read Full Article

Bausch Health Resolves Legacy SEC Investigation

Fri, 31 Jul 2020 20:43:00 Bausch Health Companies Inc. (NYSE/TSX: BHC) (and"Bausch Healthand" or the and"Companyand"), f/k/a Valeant Pharmaceuticals International, Inc. (and"Valeantand"), today announced the successful resolution of the legacy investigation by the U.S. Securities and Exchange Commission (...... Read Full Article

Earnings Preview: Bausch Health (BHC) Q2 Earnings Expected to Decline

Thu, 30 Jul 2020 16:33:04 Bausch (BHC) doesnand't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.... Read Full Article

Ortho Dermatologics Announces 2020 Aspire Higher Scholarship Recipients

Tue, 28 Jul 2020 11:00:00 Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, today announced the recipients of their 2020 Aspire Higher scholarship program. The program, which began in 2012, will award nine ...... Read Full Article

Bausch Health Companies Inc. Will Release Second-Quarter 2020 Financial Results On August 6

Thu, 23 Jul 2020 11:00:00 LAVAL, QC, July 23, 2020 /CNW/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) (and"Bausch Healthand" or the and"Companyand") will release its second-quarter 2020 financial results on Thursday, Aug. 6, 2020. Bausch Health will host a conference call and live web cast at 8:00 ...... Read Full Article

What We Learned About Bausch Health Companiesand' (NYSE:BHC) CEO Compensation

Tue, 14 Jul 2020 14:03:12 Joseph Papa became the CEO of Bausch Health Companies Inc. (NYSE:BHC) in 2016, and we think itand's a good time to look...... Read Full Article

Did Hedge Funds Make The Right Call On Bausch Health Companies Inc. (BHC) ?

Fri, 10 Jul 2020 01:23:41 At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile markets we scrutinize hedge fund ...... Read Full Article

Bill Ackman on Becoming an Activist Investor

Mon, 29 Jun 2020 22:37:59 The veteran investor also reflects on principles to embrace Continue reading...... Read Full Article

Moves by Bill Ackman, Jeffrey Ubben Indicate Change Is Afoot in the World of Hedge Funds

Thu, 25 Jun 2020 22:17:00 Pershing Square’s Bill Ackman has formed a giant special purpose acquisition company to snag a “mature unicorn.” ValueAct’s Jeffrey Ubben left the fund he founded to fully dive into ESG.... Read Full Article

Ortho Dermatologics Launches ARAZLO™ (tazarotene) Lotion, 0.045%, In The United States

Tue, 23 Jun 2020 11:00:00 Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses in the world, today announced that ARAZLO™ (tazarotene) Lotion, 0.045%, is available commercially to health care professionals in the ...... Read Full Article

BAUSCH + LOMB ULTRA® Silicone Hydrogel Contact Lenses Receive Approval In China

Wed, 17 Jun 2020 20:15:00 Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) (and"Bausch Healthand"), today announced that BAUSCH + LOMB ULTRA® monthly silicone hydrogel contact lenses have received approval from the National Medical Products Administration in ...... Read Full Article

Bausch Health to Participate at Goldman Sachs Annual Leveraged Finance Conference

Tue, 16 Jun 2020 11:00:00 Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that Paul S. Herendeen, executive vice president and chief financial officer, Arthur J. Shannon, senior vice president and head of Investor Relations and Communications, and William Woodfield, vice president and treasurer, ...... Read Full Article

Salix Announces Inaugural Salix Gastrointestinal Health Scholars Program Recipients

Mon, 15 Jun 2020 11:00:00 Bausch Health Companies Inc. (NYSE/TSX: BHC) and its gastroenterology business, Salix Pharmaceuticals (and"Salixand"), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal (GI) diseases, today announced the recipients of ...... Read Full Article

Health Canada Issues Notice of Compliance for Bausch Health's DUOBRII™

Thu, 11 Jun 2020 11:00:00 Health Canada Issues Notice of Compliance for Bausch Health's DUOBRII™... Read Full Article

FDA Provides 510(k) Clearance For BAUSCH + LOMB INFUSE™ Daily Disposable Silicone Hydrogel (SiHy Daily) Contact Lenses

Thu, 04 Jun 2020 11:00:00 Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) (and"Bausch Healthand"), today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for BAUSCH + LOMB INFUSE™ ...... Read Full Article

Bausch + Lomb Announces The European Launch Of LuxSmart™ And LuxGood™ Preloaded Intraocular Lenses

Wed, 27 May 2020 11:00:00 Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) (and"Bausch Healthand"), today announced the European launch of the companyand's first Extended Depth of Focus intraocular lens (IOL), LuxSmart™, and a new monofocal ...... Read Full Article
<